Literature DB >> 2354993

Late events following repair of aortic coarctation with resection and end-to-end anastomosis: a twenty-five-year experience.

L B McGrath1, L Gonzalez-Lavin, S B Amini, D Graf.   

Abstract

From November 24, 1964 through July 3, 1979, 81 patients underwent coarctation repair with resection and end-to-end anastomosis. Mean age at operation was 13.4 years, with a range of 4 months to 55 years. Thirty-two patients (39%) had associated cardiac defects. There were no hospital deaths. Eighty of the 81 hospital survivors were followed (99%) for a total of 10,780 months postoperatively, at a mean of 134.6 (+/- 7.1) months. There was one late death (1.3%) of a ruptured berry aneurysm at 120 months after repair. Actuarial survival was 100% at 10 years and 92.9 +/- 7% at 20 years. Five patients (6.3%) required late re-repair at a mean of 142.8 months postoperatively, range 85 months to 195 months. Actuarial freedom from reoperation was 97 +/- 2.0% at 5 years and 91.7 +/- 3.6% at 20 years. Earlier age at initial repair (P = 0.002), higher mean transrepair gradient (P = 0.005), and late hypertension (P = 0.08) were associated with re-coarctation. The hazard function for reoperation according to age at initial repair revealed a single early risk phase with a plateau starting at 7 years of age and zero hazard after 10 years of age. We conclude that correction of coarctation of the aorta using resection and end-to-end anastomosis permits a long history of event-free survival and continues to be an excellent method of repair.

Entities:  

Mesh:

Year:  1990        PMID: 2354993     DOI: 10.1007/bf02058324

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  28 in total

1.  The use of absorbable monofilament polydioxanone suture in pediatric cardiovascular operations.

Authors:  J L Myers; D B Campbell; J A Waldhausen
Journal:  J Thorac Cardiovasc Surg       Date:  1986-10       Impact factor: 5.209

2.  Surgical treatment of coarctation of the aorta in a ten week old infant: report of a case.

Authors:  J W KIRKLIN; H B BURCHELL; D G PUGH; E C BURKE; S D MILLS
Journal:  Circulation       Date:  1952-09       Impact factor: 29.690

3.  Subclavian steal syndrome in the pediatric age group.

Authors:  F M Midgley; J E McClenathan
Journal:  Ann Thorac Surg       Date:  1977-09       Impact factor: 4.330

4.  Coarctation of the aorta in infancy. Postoperative follow-up.

Authors:  C Pelletier; A Davignon; M F Ethier; P Stanley
Journal:  J Thorac Cardiovasc Surg       Date:  1969-02       Impact factor: 5.209

5.  Vascular anastomoses in growing vessels: the use of absorbable sutures.

Authors:  J L Myers; J A Waldhausen; W E Pae; A B Abt; G A Prophet; W S Pierce
Journal:  Ann Thorac Surg       Date:  1982-11       Impact factor: 4.330

6.  Vascular consequences of subclavian artery transection for the treatment of congenital heart disease.

Authors:  F A Lodge; J J Lamberti; A H Goodman; S E Kirkpatrick; L George; J W Mathewson; J D Waldman
Journal:  J Thorac Cardiovasc Surg       Date:  1983-07       Impact factor: 5.209

7.  Ischemic injury to the brachial plexus following subclavian flap aortoplasty.

Authors:  C E Lawless; R N Sapsford; C Pallis; K A Hallidie-Smith
Journal:  J Thorac Cardiovasc Surg       Date:  1982-11       Impact factor: 5.209

8.  Subclavian arterioplasty. Repair of coarctation of the aorta in the first year of life.

Authors:  P A Penkoske; W G Williams; P M Olley; J LeBlanc; G A Trusler; C A Moes; R Judakin; R D Rowe
Journal:  J Thorac Cardiovasc Surg       Date:  1984-06       Impact factor: 5.209

9.  Upper extremity gangrene: a complication of subclavian artery division.

Authors:  D Geiss; W G Williams; W K Lindsay; R D Rowe
Journal:  Ann Thorac Surg       Date:  1980-11       Impact factor: 4.330

10.  Coarctation of the aorta in patients younger than three months. A critique of the subclavian flap operation.

Authors:  A Cobanoglu; J F Teply; G L Grunkemeier; C O Sunderland; A Starr
Journal:  J Thorac Cardiovasc Surg       Date:  1985-01       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.